High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease
Tejpar, S., Piessevaux, H., Humblet, Y., De Roock, W., Biesemans, B., De Schutter, J., Peeters, M., Celik, I., & Van Cutsem, E. (2007). High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease. Molecular Cancer Therapeutics, 6(12), 3466S-3466S. (Original work published 2007)